School of Pharmacy and Allied Health Sciences has earned its best-ever ranking among U.S.
pharmacy schools for research dollars awarded by the National Institutes of Health.
released in February by the American Association of Colleges of Pharmacy indicate that out
of 80 pharmacy schools 57 having NIH funding UM ranked 28th in total amount
of NIH funding awarded.
More impressively, when the statistics were based on the amount of funding per
faculty member with doctoral research training, The University of Montana ranked
16th, pharmaceutical sciences Chair Vernon Grund says. Using this statistic,
UM would rank ahead of such schools of pharmacy as USC, Minnesota, Arizona, Washington and
Georgia and just behind Purdue, 14th, and Wisconsin, 15th.
If the statistics were applied to the 23 EPSCoR (Experimental Program to Stimulate
Competitive Research) states, Grund says, UM would rank fourth behind Kansas, Mississippi
and Kentucky for NIH funding. Based on awards per faculty member with doctoral research
training, UM would rank second behind only Kansas. UMs total NIH funding for fiscal
year 1999 was just under $1,050,500.
This phenomenal growth has occurred only over the past 10 years, he says.
More significantly, we already have plans in place to enhance this productivity by
at least 50 percent over the next two to four years, especially as we establish the Center
for Environmental Health Sciences and recruit the new faculty to be affiliated with this
center. The bottom line is, were not resting on our laurels and the progress to
date. Were really moving up quickly.
Biomedical research funding supports faculty research and is an important component of
a health sciences program, Grund says. Interacting with faculty members involved in
cutting-edge scholarship enhances students educational experiences and sets
the groundwork for preparing a superior health-care professional, he says.